HEXACOSANOIC ACID

HEXACOSANOIC ACID is a lipid of Fatty Acyls (FA) class. Hexacosanoic acid is associated with abnormalities such as Adrenoleukodystrophy, Adrenal gland hypofunction and Chronic liver disease NOS. The involved functions are known as peroxisome targeting signal-2 binding activity, Oxidation, Demyelination, Mutation and Biosynthetic Pathways. Hexacosanoic acid often locates in peroxisome, Body tissue, Mitochondria, Membrane and Cytoplasm. The associated genes with HEXACOSANOIC ACID are ABCD1 gene, TRAM1 gene, GPX1 gene, SOD1 gene and SOD2 gene. The related lipids are Fatty Acids, Stearic acid, inositolphosphorylceramide, Very long chain fatty acid and Nonesterified Fatty Acids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of HEXACOSANOIC ACID, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEXACOSANOIC ACID?

HEXACOSANOIC ACID is suspected in Adrenoleukodystrophy, Adrenal gland hypofunction, Chronic liver disease NOS and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEXACOSANOIC ACID

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Liver Diseases D008107 31 associated lipids
Kidney Diseases D007674 29 associated lipids
Leukemia P388 D007941 43 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Diffuse Cerebral Sclerosis of Schilder D002549 8 associated lipids
Arteriosclerosis D001161 86 associated lipids
Metabolic Diseases D008659 12 associated lipids
Adrenocortical Hyperfunction D000308 3 associated lipids
Per page 10 20 | Total 17

PubChem Associated disorders and diseases

What pathways are associated with HEXACOSANOIC ACID

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEXACOSANOIC ACID?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEXACOSANOIC ACID?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEXACOSANOIC ACID?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with HEXACOSANOIC ACID?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEXACOSANOIC ACID?

Knock-out

Knock-out are used in the study 'A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis.' (Fourcade S et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with HEXACOSANOIC ACID

Download all related citations
Per page 10 20 50 100 | Total 136
Authors Title Published Journal PubMed Link
Ohta M et al. Novel free ceramides as components of the soldier defense gland of the Formosan subterranean termite (Coptotermes formosanus). 2007 J. Lipid Res. pmid:17164223
Gunasekera SP et al. Constituents of Nealchornea yapurenis (Euophorbiaceae). 1980 Mar-Apr J. Nat. Prod. pmid:7381509
Tsuji S et al. Metabolism of [17,18-3H2]hexacosanoic acid and [15,16-3H2]lignoceric acid in cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN). 1985 J. Neurol. Sci. pmid:4087029
Deon M et al. The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy. 2006 J. Neurol. Sci. pmid:16750542
Wanders RJ et al. Infantile phytanic acid storage disease, a disorder of peroxisome biogenesis: a case report. 1990 J. Neurol. Sci. pmid:1700075
Sereni C et al. Adult adrenoleukodystrophy: a sporadic case? 1987 J. Neurol. Sci. pmid:3681326
Sakai T et al. Very long-chain fatty acids in neutral lipids and glycerophospholipids of adrenoleukodystrophy-cultured skin fibroblasts. 1985 J. Neurol. Sci. pmid:4087027
Yamamoto Y et al. Chemical Synthesis of a Very Long-Chain Fatty Acid, Hexacosanoic Acid (C26:0), and the Ceramide Containing Hexacosanoic Acid. 2015 J. Nutr. Sci. Vitaminol. pmid:26226958
Kawahara K et al. Hexacosanoate contents in Japanese common foods. 1988 J. Nutr. Sci. Vitaminol. pmid:3244051
Wanders RJ et al. Impaired ability of peroxisomes to activate very-long-chain fatty acids in X-linked adrenoleukodystrophy. 1988 Lancet pmid:2899227
Yanagisawa N et al. Enhanced production of nitric oxide, reactive oxygen species, and pro-inflammatory cytokines in very long chain saturated fatty acid-accumulated macrophages. 2008 Lipids Health Dis pmid:19038055
Deon M et al. Hexacosanoic and docosanoic acids plasma levels in patients with cerebral childhood and asymptomatic X-linked adrenoleukodystrophy: Lorenzo's oil effect. 2008 Metab Brain Dis pmid:18026827
Rockenbach FJ et al. The effect of bone marrow transplantation on oxidative stress in X-linked adrenoleukodystrophy. 2012 Mol. Genet. Metab. pmid:22525090
Hubbard WC et al. Combined liquid chromatography-tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings. 2006 Sep-Oct Mol. Genet. Metab. pmid:16828324
Pai GS et al. Lovastatin therapy for X-linked adrenoleukodystrophy: clinical and biochemical observations on 12 patients. 2000 Mol. Genet. Metab. pmid:10870849
Wilkins A et al. Very long chain fatty acid levels in patients diagnosed with multiple sclerosis. 2009 Mult. Scler. pmid:19965514
Engelen M et al. Lovastatin in X-linked adrenoleukodystrophy. 2010 N. Engl. J. Med. pmid:20089986
Sadeghi-Nejad A and Senior B Adrenomyeloneuropathy presenting as Addison's disease in childhood. 1990 N. Engl. J. Med. pmid:2294415
Moser AE et al. The cerebrohepatorenal (Zellweger) syndrome. Increased levels and impaired degradation of very-long-chain fatty acids and their use in prenatal diagnosis. 1984 N. Engl. J. Med. pmid:6709009
Xue Q et al. Two new compounds from Semen celosiae and their protective effects against CClâ‚„-induced hepatotoxicity. 2011 Nat. Prod. Res. pmid:20306359